Gain Therapeutics prices $11M public offering of common stock and pre-funded warrants

Gain Therapeutics, Inc.

Offering of 7,116,547 shares at $1.35/share and 1,031,602 pre-funded warrants at $1.3499 each.
Gross proceeds of ~$11M; net proceeds of ~$10.1M after discounts and expenses.
Proceeds to fund clinical development of GT-02287 for GBA1 Parkinson's disease.
Underwriter Titan Partners granted 30-day option for 1,222,222 additional shares (15% over-allotment).
Underwriter warrants for 570,370 shares at $1.6875, exercisable 6 months post-closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.